Incyte Corporation (INCY)

Incyte Corporation (INCY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $23.5B; returns 1 day -1.0%, 1 week +2.3%, 1 year +29.6%.

Incyte Corporation is a biopharmaceutical company specializing in the discovery and commercialization of proprietary therapeutics, with a core focus on hematology, oncology, and inflammation/autoimmunity (IAI).

Groups INCY belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• S&P 500
• Pharmaceuticals
• Commercial Stage Biotech
• Oncology
• Hematology
• Autoimmune Diseases
• Royalty Streams
• Dermatology
• Rare Diseases
• Hematologic Malignancies
• Drug Discovery
• Life Sciences

INCY financial model: income statement, cash flow and balance sheet